182 related articles for article (PubMed ID: 35216581)
21. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
[TBL] [Abstract][Full Text] [Related]
22. Effects of correcting metabolic acidosis on muscle mass and functionality in chronic kidney disease: a systematic review and meta-analysis.
Visser WJ; van de Braak EEM; de Mik-van Egmond AME; van der Burgh AC; de Roos NM; Jans I; van der Hoef I; Olieman JF; Hoorn EJ; Severs D
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2498-2508. PubMed ID: 37728018
[TBL] [Abstract][Full Text] [Related]
23. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
[TBL] [Abstract][Full Text] [Related]
24. Low Serum Bicarbonate and CKD Progression in Children.
Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
[TBL] [Abstract][Full Text] [Related]
25. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
[TBL] [Abstract][Full Text] [Related]
26. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
Trials; 2013 Jul; 14():196. PubMed ID: 23826760
[TBL] [Abstract][Full Text] [Related]
27. Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
Căpuşă C; Ştefan G; Stancu S; Lipan M; Tsur LD; Mircescu G
Medicine (Baltimore); 2017 Nov; 96(47):e8802. PubMed ID: 29381982
[TBL] [Abstract][Full Text] [Related]
28. Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.
Adamczak M; Surma S
Kidney Dis (Basel); 2021 Nov; 7(6):452-467. PubMed ID: 34901192
[TBL] [Abstract][Full Text] [Related]
29. Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences.
Fernandez-Prado R; Villalvazo P; Avello A; Gonzalez-de-Rivera M; Aguirre M; Carrasco-Muñoz CG; Fernandez-Fernandez B; Martin-Cleary C; Carriazo S; Sanchez-Niño MD; Perez-Gomez MV; Ortiz A
Biomed Pharmacother; 2023 Feb; 158():114197. PubMed ID: 36916426
[TBL] [Abstract][Full Text] [Related]
30. Oral sodium bicarbonate improves thyroid function in predialysis chronic kidney disease.
Disthabanchong S; Treeruttanawanich A
Am J Nephrol; 2010; 32(6):549-56. PubMed ID: 21042013
[TBL] [Abstract][Full Text] [Related]
31. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
[TBL] [Abstract][Full Text] [Related]
32. Metabolic Acidosis in CKD: A Review of Recent Findings.
Melamed ML; Raphael KL
Kidney Med; 2021; 3(2):267-277. PubMed ID: 33851122
[TBL] [Abstract][Full Text] [Related]
33. Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults.
Dobre M; Gaussoin SA; Bates JT; Chonchol MB; Cohen DL; Hostetter TH; Raphael KL; Taylor AA; Lerner AJ; Wright JT; Rahman M;
Clin J Am Soc Nephrol; 2018 Apr; 13(4):596-603. PubMed ID: 29567858
[TBL] [Abstract][Full Text] [Related]
34. Effects of oral sodium bicarbonate in patients with CKD.
Abramowitz MK; Melamed ML; Bauer C; Raff AC; Hostetter TH
Clin J Am Soc Nephrol; 2013 May; 8(5):714-20. PubMed ID: 23393105
[TBL] [Abstract][Full Text] [Related]
35. Dietary Acid Load is Associated With Serum Bicarbonate but not Insulin Sensitivity in Chronic Kidney Disease.
Ikizler HO; Zelnick L; Ruzinski J; Curtin L; Utzschneider KM; Kestenbaum B; Himmelfarb J; de Boer IH
J Ren Nutr; 2016 Mar; 26(2):93-102. PubMed ID: 26508542
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease - Position Statement of the Working Group of the Polish Society of Nephrology.
Adamczak M; Masajtis-Zagajewska A; Mazanowska O; Madziarska K; Stompór T; Więcek A
Kidney Blood Press Res; 2018; 43(3):959-969. PubMed ID: 29895022
[TBL] [Abstract][Full Text] [Related]
37. Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease.
Tanemoto M; Kamachi R; Kimura T; Yamada S; Yokoyama T; Okazaki Y
Clin Exp Nephrol; 2020 Dec; 24(12):1140-1143. PubMed ID: 32772208
[TBL] [Abstract][Full Text] [Related]
38. Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study.
Kim HJ; Kang E; Ryu H; Han M; Lee KB; Kim YS; Sung S; Ahn C; Oh KH
Sci Rep; 2019 Nov; 9(1):16139. PubMed ID: 31695082
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.
Raphael KL
J Am Soc Nephrol; 2018 Feb; 29(2):376-382. PubMed ID: 29030467
[TBL] [Abstract][Full Text] [Related]
40. Association of serum bicarbonate with bone fractures in hemodialysis patients: the mineral and bone disorder outcomes study for Japanese CKD stage 5D patients (MBD-5D).
Kato A; Kido R; Onishi Y; Kurita N; Fukagawa M; Akizawa T; Fukuhara S
Nephron Clin Pract; 2014; 128(1-2):79-87. PubMed ID: 25378374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
